Evidence map›Paper›PMID 22566935›Full record

ArticleFrontiers in immunology2012

Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation.

Sarah Bruneau, Craig Bryan Woda, Kevin Patrick Daly, Leonard Boneschansker, Namrata Gargee Jain, Nora Kochupurakkal, Alan Gabriel Contreras, Tatsuichiro Seto, David Michael Briscoe

Abstract read
In one paragraph

Article in Frontiers in immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Immunomodulation by allograft endothelial cells.Frontiers in transplantation · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. A Critical Role for Airway Microvessels in Lung Transplantation.American journal of respiratory and critical care medicine · 2016
    Article
  17. Review
  18. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sarah BruneauThe Division of Nephrology, Transplantation Research Center, Children's Hospital Boston Boston, MA, USA.
Craig Bryan Woda
Kevin Patrick Daly
Leonard Boneschansker
Namrata Gargee Jain
Nora Kochupurakkal
Alan Gabriel Contreras
Tatsuichiro Seto
David Michael Briscoe

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
RESEARCH METHODS IN PEDIATRICS HEART DISEASET32HL007572 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI Sarah D DE FERRANTI, Jane W. Newburger · 1985 to 2026
$13.0M
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007726 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 1994 to 2023
$5.9M
ANGIOGENESIS AND CHRONIC REJECTIONR01AI046756 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 2000 to 2010
$4.2M
Vascular Endothelial Growth Factor Receptor Interactions and Allograft RejectionR01AI092305 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI BRISCOE, DAVID M. · 2012 to 2016
$2.8M
VASCULAR ENDOTHELIAL GROWTH FACTOR IN ALLOIMMUNITYR01HL074436 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 2003 to 2007
$2.0M
Role of T cell Specific Adaptor Protein in AlloimmunityR21AI092399 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI BRISCOE, DAVID M. · 2011 to 2012
$478k
NOVEL IN VIVO MODEL OF CHRONIC ALLOGRAFT REJECTIONR21HL104602 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI BRISCOE, DAVID M. · 2010 to 2011
$475k
NCRR NIH HHS UL1 RR025758NHLBI NIH HHS L40 HL110356NHLBI NIH HHS R01 HL074436NHLBI NIH HHS R21 HL104602NHLBI NIH HHS T32 HL007572NIAID NIH HHS R01 AI046756NIAID NIH HHS R01 AI092305NIAID NIH HHS R21 AI092399NIDDK NIH HHS T32 DK007726
6 · The paper itself

Abstract

In this review, we discuss how changes in the intragraft microenvironment serve to promote or sustain the development of chronic allograft rejection. We propose two key elements within the microenvironment that contribute to the rejection process. The first is endothelial cell proliferation and angiogenesis that serve to create abnormal microvascular blood flow patterns as well as local tissue hypoxia, and precedes endothelial-to-mesenchymal transition. The second is the overexpression of local cytokines and growth factors that serve to sustain inflammation and, in turn, function to promote a leukocyte-induced angiogenesis reaction. Central to both events is overexpression of vascular endothelial growth factor (VEGF), which is both pro-inflammatory and pro-angiogenic, and thus drives progression of the chronic rejection microenvironment. In our discussion, we focus on how inflammation results in angiogenesis and how leukocyte-induced angiogenesis is pathological. We also discuss how VEGF is a master control factor that fosters the development of the chronic rejection microenvironment. Overall, this review provides insight into the intragraft microenvironment as an important paradigm for future direction in the field.

Indexed as

allograft rejectionallograft vasculopathyangiogenesischronic allograft rejectionendothelial cellhypoxiamicrovascular injuryvascular endothelial growth factor

Identifiers

PMID22566935
PMCPMC3342046

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.